BSG and neoplasm: The same Chinese group later developed another human-mouse chimeric antibody that recognized the EC-2 domain of CD147 named metuzumab (160), and showed that it was efficient in inhibiting tumor growth in xenograft models of lung cancer human in SCID mice, and could sensitize tumor cells to chemotherapy (161).